Avanir Pharmaceuticals, Inc. (AVNR) Posts Better-Than-Expected Q1 Results

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $6.49 million.

For earnings history and earnings-related data on Avanir Pharmaceuticals, Inc. (AVNR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec
• Portland General Electric halts holding company restructuring plan